Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Sexually transmitted infections tests and treatment news

Show

From To
HIV infection doesn't generally affect the response to syphilis treatment

Well-controlled HIV infection does not have a significant impact on the serological response to treatment for syphilis, Swiss investigators report in the online edition of Clinical Infectious

Published
18 September 2012
By
Michael Carter
Reduced susceptibility to first-line drug causes change in UK gonorrhoea prescribing practice

UK Prescribing guidance for the treatment of gonorrhoea needs to change because of increasing prevalence of bacteria with reduced susceptibility to the first-line antibiotic cefixime, the Health

Published
11 October 2011
By
Michael Carter
Herpes drugs and viral load: valaciclovir works better than aciclovir

The anti-herpes drug valaciclovir (Valtrex, valacyclovir in the US) produced a 17-fold (1.23 log) reduction in HIV viral load in Kenyan patients not taking treatment, the sixth

Published
26 July 2011
By
Gus Cairns
Daily aciclovir slows HIV disease progression and reduces viral load

Daily treatment with standard-dose aciclovir delays HIV disease progression and lowers viral load in patients co-infected with herpes simplex virus-2 (HSV-2), results of a study presented to the

Published
19 July 2011
By
Michael Carter
Guidelines for treatment of syphilis in patients with HIV have very poor evidence base

Current guidelines for the treatment of syphilis in patients with HIV are based on limited clinical data, investigators show in the online edition of Sexually Transmitted Infections. Even

Published
21 October 2010
By
Michael Carter
One in ten people in UK with gonorrhoea have a strain with reduced susceptibility to treatment

Depending of the definition of ‘resistance’ used, between 1% and 10% of people with gonorrhoea in the UK have a strain which is resistant to the antibiotic

Published
25 August 2010
By
Roger Pebody
Popular opinion leaders add no benefit to intensive HIV prevention

HIV prevention using ‘popular opinion leaders’ is no more effective at reducing risky sexual behaviour and the incidence of sexually transmitted infections than prevention consisting

Published
07 April 2010
By
Michael Carter
Aciclovir shows lower efficacy outside US in global trial

Aciclovir’s efficacy in preventing genital ulcers and lowering herpes simplex virus-2 load varied significantly between the US and resource poor countries, investigators from a large

Published
19 March 2010
By
Michael Carter
Topical treatment for pre-cancerous anal cell changes safe and moderately effective

A course of treatment with topical trichloroacetic acid appears to provide a safe and effective treatment for pre-cancerous cell changes in the anus, US investigators

Published
05 October 2009
By
Michael Carter
Scientists learn why even treated genital herpes sores boost the risk of HIV infection

New research helps explain why infection with herpes simplex virus-2 (HSV-2), which causes genital herpes, increases the risk for HIV infection even after successful treatment

Published
05 August 2009
By
NIAID Press Release

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.